Brr Op Co, LLC Eli Lilly & CO Transaction History

Brr Op Co, LLC

$815 Million
Q3 2022

A detailed history of Brr Op Co, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Brr Op Co, LLC holds 25,611 shares of LLY stock, worth $20.4 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

25,611

Previous 23,167 10.55%

Holding current value

$20.4 Million

Previous $7.51 Million 10.24%

% of portfolio

1.02%

Previous 0.89%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $724,597 - $825,754	2,444 Added 10.55%	25,611 $8.28 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $44,875 - $52,690	-161 Reduced 0.69%	23,167 $7.51 Million
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $14,316 - $17,791	-61 Reduced 0.26%	23,328 $6.68 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $68,579 - $85,107	-305 Reduced 1.29%	23,389 $6.46 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $371,401 - $457,061	-1,676 Reduced 6.61%	23,694 $5.47 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $157,078 - $203,179	-870 Reduced 3.32%	25,370 $5.82 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $80,352 - $104,020	-489 Reduced 1.83%	26,240 $4.9 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $255,440 - $338,009	1,958 Added 7.9%	26,729 $4.51 Million
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $29,244 - $33,826	-200 Reduced 0.8%	24,771 $3.67 Million
Q2 2020 Feb 14, 2022	BUY	$136.42 - $164.18 $30,694 - $36,940	225 Added 0.91%	24,971 $4.1 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $203,129 - $244,464	1,489 Added 6.4%	24,746 $4.06 Million
Q1 2020 Feb 14, 2022	BUY	$119.05 - $147.35 $26,786 - $33,153	225 Added 0.98%	23,257 $3.23 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $26,310 - $32,564	-221 Reduced 0.95%	23,032 $3.2 Million
Q4 2019 Feb 14, 2022	BUY	$106.92 - $132.43 $2.49 Million - $3.08 Million	23,253 New	23,253 $3.06 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $2.39 Million - $2.96 Million	-22,345 Closed	0 $0
Q3 2019 Feb 14, 2022	BUY	$106.79 - $116.16 $2.39 Million - $2.6 Million	22,345 New	22,345 $2.5 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $2.38 Million - $2.59 Million	-22,325 Closed	0 $0
Q2 2019 Feb 14, 2022	BUY	$110.79 - $129.32 $2.47 Million - $2.89 Million	22,325 New	22,325 $2.47 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $2.23 Million - $2.61 Million	-20,152 Closed	0 $0
Q1 2019 Feb 14, 2022	BUY	$111.31 - $131.02 $2.24 Million - $2.64 Million	20,152 New	20,152 $2.62 Million
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $1.49 Million - $1.75 Million	-13,382 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $137,352 - $153,876	-1,297 Reduced 8.84%	13,382 $1.55 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $83,971 - $104,949	978 Added 7.14%	14,679 $1.58 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $20,439 - $23,457	-270 Reduced 1.93%	13,701 $1.17 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $9,573 - $11,300	-129 Reduced 0.91%	13,971 $1.08 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $7,046 - $7,558	86 Added 0.61%	14,100 $1.19 Million
Q3 2017 Nov 09, 2017	SELL	$77.07 - $85.54 $31,906 - $35,413	-414 Reduced 2.87%	14,014 $1.2 Million
Q2 2017 Aug 09, 2017	BUY	N/A	14,428	14,428 $1.19 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.

Account